Establishment Deferred Long Term Liab from 2010 to 2025
| ESTA Stock | USD 34.56 0.08 0.23% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 990 K | Current Value 880 K | Quarterly Volatility 59.8 K |
Check Establishment Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Establishment Labs' main balance sheet or income statement drivers, such as Interest Income of 511.2 K, Interest Expense of 9.4 M or Selling General Administrative of 173.3 M, as well as many indicators such as Price To Sales Ratio of 4.38, Dividend Yield of 0.0 or PTB Ratio of 43.51. Establishment financial statements analysis is a perfect complement when working with Establishment Labs Valuation or Volatility modules.
Establishment | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out the analysis of Establishment Labs Correlation against competitors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.59) | Revenue Per Share | Quarterly Revenue Growth 0.045 | Return On Assets | Return On Equity |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.